Stockscreener 앱 받기
14.85
2.97%
-0.5076
전일 마감가:
$15.36
열려 있는:
$15.1
하루 거래량:
725.05K
Relative Volume:
0.38
시가총액:
$2.17B
수익:
$340.81M
순이익/손실:
$-419.65M
주가수익비율:
-5.2114
EPS:
-2.85
순현금흐름:
$-402.10M
1주 성능:
-11.92%
1개월 성능:
-3.35%
6개월 성능:
-9.35%
1년 성능:
-45.23%
1일 변동 폭
$14.85
$15.29
1주일 범위
$14.87
$16.98
52주 변동 폭
$10.57
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
명칭
Denali Therapeutics Inc
전화
(650) 866-8547
주소
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
14.86 | 2.25B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.69 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.03 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.96 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.90 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.67 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | 재개 | Morgan Stanley | Overweight |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2025-01-07 | 개시 | Robert W. Baird | Outperform |
| 2025-01-03 | 개시 | William Blair | Outperform |
| 2024-12-16 | 업그레이드 | Stifel | Hold → Buy |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-10-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | 개시 | Citigroup | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 개시 | B. Riley Securities | Buy |
| 2023-01-30 | 개시 | SVB Securities | Outperform |
| 2022-12-05 | 개시 | Cowen | Outperform |
| 2022-11-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-02 | 개시 | BofA Securities | Buy |
| 2022-06-23 | 개시 | Berenberg | Buy |
| 2021-12-10 | 재개 | Raymond James | Mkt Perform |
| 2021-09-21 | 개시 | Oppenheimer | Outperform |
| 2021-09-01 | 개시 | SMBC Nikko | Outperform |
| 2021-05-18 | 개시 | UBS | Buy |
| 2021-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-08-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-02-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-02-24 | 개시 | Jefferies | Buy |
| 2020-02-19 | 개시 | Stifel | Hold |
| 2020-01-27 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-09-26 | 개시 | Wedbush | Neutral |
| 2019-09-13 | 개시 | Nomura | Buy |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
| 2018-11-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | Janney | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 개시 | Goldman | Neutral |
| 2018-01-02 | 개시 | JP Morgan | Overweight |
| 2018-01-02 | 개시 | Morgan Stanley | Overweight |
모두보기
Denali Therapeutics Inc 주식(DNLI)의 최신 뉴스
Will Denali Therapeutics Inc. (4DN) stock enhance shareholder valueJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
Will Denali Therapeutics Inc. stock outperform Nasdaq indexMarket Weekly Review & Growth Focused Investment Plans - newser.com
Will Denali Therapeutics Inc. stock gain from lower inflationInsider Buying & Real-Time Buy Signal Notifications - newser.com
Why analysts remain bullish on Denali Therapeutics Inc. stockWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com
Published on: 2025-11-04 01:41:13 - newser.com
Why Denali Therapeutics Inc. stock is favored by pension fundsMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Detecting price anomalies in Denali Therapeutics Inc. with AIJobs Report & Momentum Based Trading Signals - newser.com
Can Denali Therapeutics Inc. (4DN) stock test all time highsGap Up & Daily Oversold Bounce Ideas - newser.com
Applying sector rotation models to Denali Therapeutics Inc.Earnings Miss & Daily Profit Focused Stock Screening - newser.com
Will Denali Therapeutics Inc. (4DN) stock outperform small cap peersMarket Performance Report & High Accuracy Investment Signals - newser.com
Is Denali Therapeutics Inc. stock a top momentum play2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Is Denali Therapeutics Inc. stock a dividend growth opportunityWeekly Stock Recap & Daily Profit Maximizing Tips - newser.com
Comparing Denali Therapeutics Inc. in custom built stock radars2025 Short Interest & Fast Moving Trade Plans - newser.com
Is Denali Therapeutics Inc. stock supported by strong cash flows2025 AllTime Highs & High Accuracy Swing Trade Signals - newser.com
Is Denali Therapeutics Inc. stock ready for a breakoutAnalyst Downgrade & Risk Managed Investment Signals - newser.com
Is Denali Therapeutics Inc. stock a contrarian buy2025 Price Action Summary & Momentum Based Trading Ideas - newser.com
Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Will Denali Therapeutics Inc. stock rally after Fed decisionsJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Pier Capital LLC Sells 20,708 Shares of Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc. $DNLI Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
Published on: 2025-11-02 03:18:16 - newser.com
Savvy Advisors Inc. Invests $1.37 Million in Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc expected to post a loss of 75 cents a shareEarnings Preview - TradingView
Does Denali Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Denali Therapeutics Inc (DNLI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):